Fecal Microbiota Transplant for Transplant-Related Intestinal Damage
Treatments studied
Part of Digestive system clinical trials.
This trial tests whether transferring healthy gut bacteria from a donor to patients can help heal severe intestinal damage that occurs after bone marrow or stem cell transplants. The goal is to reduce pain, inflammation, and other complications from this serious side effect.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with transplant-related gastrointestinal mucositis (severe intestinal damage after a transplant)
- You are between 15 and 65 years old
- You are able to provide informed consent or have a guardian who can
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment called “washed microbiota transplant,” which transfers healthy gut bacteria to help relieve intestinal problems that started after cancer therapy. You might benefit if you’re an adult with certain ongoing stomach or bowel symptoms after standard cancer treatment, and your body is stable enough for the procedure.
This study tests whether transferring stool bacteria (a fecal microbiota transplant) can improve “radiation enteritis,” a bowel problem that happens after radiation treatment. It may help restore gut bacteria and reduce symptoms after your radiation therapy.
This study tests whether a fecal transplant (FMT) can help treat gut graft-versus-host disease (gut GVHD), a condition where donated immune cells attack the intestines. If you have gut GVHD and meet age requirements, you may be eligible to receive this treatment in the trial.
This trial tests whether fecal microbiota transplantation (Washed Microbiota Transplantation, or WMT) can help people who have gut problems like diarrhea, constipation, or infection after receiving a solid organ transplant. It aims to restore healthy gut bacteria.
This study tests whether a fecal microbiota transplant (FMT) — putting healthy donor bacteria into your gut — can help your immune system recover better after a stem cell transplant. It is for people whose immune markers are still low 6 months after transplant.
This Phase 2 study tests whether a fecal microbiota transplant (a processed transplant of gut bacteria) after an allogeneic bone marrow transplant is safe and helpful. Participants may benefit by improving recovery in the gut microbiome during the post-transplant period.
Hear when a new Transplant-related Gastrointestinal Mucositis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.